PATRICIA CASTRO to Myeloid-Lymphoid Leukemia Protein
This is a "connection" page, showing publications PATRICIA CASTRO has written about Myeloid-Lymphoid Leukemia Protein.
Connection Strength
0.355
-
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia. Commun Biol. 2024 10 04; 7(1):1257.
Score: 0.204
-
Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia. 2020 11; 34(11):2898-2902.
Score: 0.151